Top Story

A Conversation with Martin B. Leon, MD

Cardiology Today's Intervention, January/February 2015

For this issue, Dr. Bhatt talks with Martin B. Leon, MD, professor of medicine at Columbia University Medical Center, director of the Center for Interventional Vascular Therapy, director of the cardiac catheterization laboratories and a member of the executive board of the Columbia New York-Presbyterian Heart Valve Center, and founder and chairman emeritus of the Cardiovascular Research Foundation.

Leon completed his medical degree at Yale University School of Medicine, and his internship, residency and cardiology fellowship at Yale-New Haven Hospital. He has co-authored more than 1,550 publications, has performed more than 10,000 interventional procedures, and has served as principal investigator for more than 50 clinical trials that have helped shape the field of interventional cardiology.

Walking groups produced wide-ranging benefits

January 25, 2015
Individuals who participated in outdoor walking groups had reductions in BP, resting heart rate, total cholesterol, BMI, risk for depression and other health benefits…
In the Journals

Emotions expressed on Twitter may predict CV risk in communities

January 24, 2015
A new study suggested that it may be feasible to capture community psychological characteristics through social media. Further, these characteristics appear to be strong…
In the Journals

Impact of residential segregation on CV risk varied by race, ethnicity

January 23, 2015
The association between residential segregation and CV risk varied by race or ethnicity, according to new findings from the Multi-Ethnic Study of Atherosclerosis…
In the Journals

THUNDER: Benefit of paclitaxel-coated balloon maintained at 5 years

January 23, 2015
Use of a paclitaxel-coated balloon was associated with reduced late lumen loss, binary stenosis and target lesion revascularization at 5-year follow-up.Researchers for…
More News Headlines »
CME
Individualizing T2DM Treatment: Determining Optimal Pathways That Lead to Achieving Target Goals

Individualizing T2DM Treatment: Determining Optimal Pathways That Lead to Achieving Target Goals

This activity is supported by educational grants from Lilly USA, LLC and Novo Nordisk.

The prevalence of type 2 diabetes mellitus has escalated in recent years and targeting treatmentcontinues to be a…
More »
Meeting News Coverage Video
thumbnail for video 3945938325001

Kirk N. Garratt, MD: Prolonged DAPT beneficial in patients with paclitaxel-eluting stents

December 16, 2014
CHICAGO — In this video, Kirk N. Garratt, MD, of the Lennox Hill Hospital, New York, outlines results of a study…
More »
CME
HIV-Associated Lipodystrophy and Metabolic Complications: A Multidisciplinary Approach to Diagnosis and Treatment

HIV-Associated Lipodystrophy and Metabolic Complications: A Multidisciplinary Approach to Diagnosis and Treatment

This activity is supported by an educational grant from EMD-Serono.

Clinicians who manage patients with HIV must be aware of how to screen for, diagnose, and treat metabolic abnormalities…
More »
morganatic-roan morganatic-roan